News

British Air Cargo and Iberia Air Cargo combine to form IAG Cargo

PharmaPort -20C container is launched; Sentry BoPharma opens a -45C depot

Recent spinout from StePac, a food logistics firm, offers Xsense monitoring technology

Nanotech-based patch could make refrigerated shipping unnecessary

Kuehne-Nagel and IAG Cargo showcase new capabilities

Annual survey of leading third-party logistics providers tabulates their interest in serving manufacturers, hospitals and retail

Lack of regulatory oversight of compounding pharmacies continues to be a problem

Board undergoes annual changover

Colorcon will introduce Opadry CA and Opamix at AAPS meeting

Federal FDA inspections will now be accepted in lieu of the state's own

JD Power survey ranks mail-order and brick-and-mortar pharmacies

Spending in 2011 grew at 4.6% among employer-sponsored insurance plans

Manufacturers, distributors and healthcare providers unite to address ongoing abuse

Microencapsulation of PCMs - and new PCMs - are in the offing

Companies broaden their cold-chain shipping and storage capabilities

Recommendations help pharmacies, healthcare providers and patients deal with natural disasters or power outages

Another go at altering the lagging pace of drug research

French cold-chain supplier adds to its existing European, US and Australian depots

Ferring Pharma will work with Walgreens Specialty Pharmacy for distribution and patient education

Recently published paper proposes 13 'best research practice' principles for developing and using CER results

Latest acquisitions are Bilcare Clinical Supplies and Drug Safety Alliance Inc.

InTouch Solutions, MD Mindset collaborate to tailor iPad content development

InTouch Solutions, MD Mindset collaborate to tailor iPad content development

New Institute of Medicine report calls for a data-driven, 'continuously learning' healthcare system

Company is partnering with its retail clients to market sales activity data

Syndicated study highlights role health economics and outcomes research (HEOR) teams play in drug development

Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman

Implications for pharma are in continuing pricing pressure, and preferences for distribution channels